<VariationArchive VariationID="503904" VariationName="NM_001167.4(XIAP):c.108del (p.Pro37fs)" VariationType="Deletion" Accession="VCV000503904" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-14" DateCreated="2018-04-02" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="495793" VariationID="503904">
      <GeneList>
        <Gene Symbol="XIAP" FullName="X-linked inhibitor of apoptosis" GeneID="331" HGNC_ID="HGNC:592" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq25</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="123859708" stop="123913972" display_start="123859708" display_stop="123913972" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="122993661" stop="123047828" display_start="122993661" display_stop="123047828" Strand="+" />
          </Location>
          <OMIM>300079</OMIM>
          <Haploinsufficiency last_evaluated="2022-07-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=XIAP">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-07-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=XIAP">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001167.4(XIAP):c.108del (p.Pro37fs)</Name>
      <CanonicalSPDI>NC_000023.11:123885766:TTTT:TTT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq25</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="123885767" stop="123885767" display_start="123885767" display_stop="123885767" variantLength="1" positionVCF="123885766" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="123019617" stop="123019617" display_start="123019617" display_stop="123019617" variantLength="1" positionVCF="123019616" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>P37fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001167.3" sequenceAccession="NM_001167" sequenceVersion="3" change="c.108delT">
            <Expression>NM_001167.3:c.108delT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.123019620del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.123019620del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.123885770del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.123885770del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007264.1" sequenceAccession="NG_007264" sequenceVersion="1" change="g.30573del">
            <Expression>NG_007264.1:g.30573del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001167.4" sequenceAccession="NM_001167" sequenceVersion="4" change="c.108del" MANESelect="true">
            <Expression>NM_001167.4:c.108del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001158.2" sequenceAccession="NP_001158" sequenceVersion="2" change="p.Pro37fs">
            <Expression>NP_001158.2:p.Pro37fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001204401.2" sequenceAccession="NM_001204401" sequenceVersion="2" change="c.108del">
            <Expression>NM_001204401.2:c.108del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001191330.1" sequenceAccession="NP_001191330" sequenceVersion="1" change="p.Pro37fs">
            <Expression>NP_001191330.1:p.Pro37fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378590.1" sequenceAccession="NM_001378590" sequenceVersion="1" change="c.108del">
            <Expression>NM_001378590.1:c.108del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365519.1" sequenceAccession="NP_001365519" sequenceVersion="1" change="p.Pro37fs">
            <Expression>NP_001365519.1:p.Pro37fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378591.1" sequenceAccession="NM_001378591" sequenceVersion="1" change="c.108del">
            <Expression>NM_001378591.1:c.108del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365520.1" sequenceAccession="NP_001365520" sequenceVersion="1" change="p.Pro37fs">
            <Expression>NP_001365520.1:p.Pro37fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378592.1" sequenceAccession="NM_001378592" sequenceVersion="1" change="c.108del">
            <Expression>NM_001378592.1:c.108del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365521.1" sequenceAccession="NP_001365521" sequenceVersion="1" change="p.Pro37fs">
            <Expression>NP_001365521.1:p.Pro37fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_19" sequenceAccession="LRG_19">
            <Expression>LRG_19:g.30573del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658799861" DB="ClinGen" />
        <XRef Type="rs" ID="1556404455" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001167.4(XIAP):c.108del (p.Pro37fs) AND not provided" Accession="RCV000599327" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-12-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001167.4(XIAP):c.108del (p.Pro37fs) AND X-linked lymphoproliferative disease due to XIAP deficiency" Accession="RCV000696547" Version="4">
        <ClassifiedConditionList TraitSetID="3179">
          <ClassifiedCondition DB="MedGen" ID="C1845076">X-linked lymphoproliferative disease due to XIAP deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-06-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-06-06" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-04-02" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17080092</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21119115</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25666262</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3179" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2711" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lymphoproliferative syndrome 2, X-linked</ElementValue>
                <XRef ID="X-linked+lymphoproliferative+syndrome+2/9494" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XIAP DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="300635" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">X-linked lymphoproliferative disease due to XIAP deficiency</ElementValue>
                <XRef ID="MONDO:0010385" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">XLP2</ElementValue>
                <XRef Type="MIM" ID="300635" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">XIAP-Related Lymphoproliferative Disease, X-Linked</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">X-linked lymphoproliferative disease (XLP) has two recognizable subtypes, XLP1 and XLP2. XLP1 is characterized predominantly by one of three commonly recognized phenotypes: Inappropriate immune response to Epstein-Barr virus (EBV) infection leading to hemophagocytic lymphohistiocytosis (HLH) or severe mononucleosis. Dysgammaglobulinemia. Lymphoproliferative disease (malignant lymphoma). XLP2 is most often characterized by HLH (often associated with EBV), dysgammaglobulinemia, and inflammatory bowel disease. HLH resulting from EBV infection is associated with an unregulated and exaggerated immune response with widespread proliferation of cytotoxic T cells, EBV-infected B cells, and macrophages. Dysgammaglobulinemia is typically hypogammaglobulinemia of one or more immunoglobulin subclasses. The malignant lymphomas are typically B-cell lymphomas, non-Hodgkin type, often extranodal, and in particular involving the intestine.</Attribute>
                <XRef ID="NBK1406" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10916" />
                <XRef ID="10916" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301580</ID>
                <ID Source="BookShelf">NBK1406</ID>
              </Citation>
              <XRef ID="2442" DB="Orphanet" />
              <XRef ID="538934" DB="Orphanet" />
              <XRef ID="C1845076" DB="MedGen" />
              <XRef ID="MONDO:0010385" DB="MONDO" />
              <XRef Type="MIM" ID="300635" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1390209" SubmissionDate="2019-01-29" DateLastUpdated="2018-04-02" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="GDX:1859493|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000710203" DateUpdated="2018-04-02" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.108delT variant in the XIAP gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.108delT variant causes a frameshift starting with codon Proline 37, changes this amino acid to a Glutamine residue, and creates a premature Stop codon at position 34 of the new reading frame, denoted p.P37QfsX34. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.108delT variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.108delT as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="XIAP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001167.3:c.108delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1596911" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="4067371|MedGen:C1845076" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000825111" DateUpdated="2024-02-14" DateCreated="2018-10-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-06-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17080092</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21119115</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25666262</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro37Glnfs*34) in the XIAP gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with XIAP-related disease. Loss-of-function variants in XIAP are known to be pathogenic (PMID: 17080092, 21119115, 25666262). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="XIAP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.123019617del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1845076" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB4474525</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1390209" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1596911" TraitType="Disease" MappingType="XRef" MappingValue="C1845076" MappingRef="MedGen">
        <MedGen CUI="C1845076" Name="X-linked lymphoproliferative disease due to XIAP deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

